Duloxetine EP Impurity C
|
度洛西汀EP雜質(zhì)C
|
949095-98-1
|
Pantoprazole EP Impurity E (Dimer)
|
泮托拉唑EP雜質(zhì)E(二聚體)
|
2115779-15-0
|
Febuxostat Impurity 73
|
非布司他雜質(zhì)73
|
5203-15-6
|
Budesonide EP Impurity L (Budesonide USP Related Compound L, 11-Keto Budesonide) (Mixture of Diastereomers)
|
布地奈德EP雜質(zhì)L(布地奈德USP相關(guān)化合物L(fēng),11-酮-布地奈德)(雙立體異構(gòu)體混合物)
|
216453-74-6
|
Pantoprazole Impurity 53
|
泮托拉唑雜質(zhì)53
|
957470-59-6
|
Febuxostat metabolite 67M-2
|
非布索坦代謝產(chǎn)物67M-2
|
407582-47-2
|
Hydrocortisone 17-Butyrate 3-Enol Methyl Ether
|
氫化可的松17丁酸3-烯醇甲醚
|
|
Salmeterol EP Impurity E (Salmeterol USP Related Compound B)
|
沙美特羅EP雜質(zhì)E(沙美特羅USP相關(guān)化合物B)對照品
|
108928-81-0
|
Methylprednisolone EP Impurity D
|
甲潑尼松EP雜質(zhì)D
|
1338549-02-2
|
Nintedanib Impurity 3 (Intedanib Impurity 3)
|
尼達尼布雜質(zhì)3(阿達尼雜質(zhì)3)
|
1168150-46-6
|
Paroxetine Impurity 10 HCl
|
帕羅西汀雜質(zhì)10鹽酸
|
|
Moxifloxacin Impurity 7
|
莫西沙星雜質(zhì)7
|
|
Brivaracetam Impurity 36
|
布瓦西坦雜質(zhì)36
|
357338-13-7
|
Paliperidone Heptadecanoate
|
庚二酸帕利哌酮
|
1404053-62-8
|
Procaterol Impurity 3
|
丙卡特羅雜質(zhì)3
|
|
Hydrocortisone EP Impurity N
|
氫化可的松EP雜質(zhì)N
|
|
Prednisolone EP Impurity C (Hydrocortisone Acetate EP Impurity C, Methylprednisolone Acetate EP Impurity E, Prednisone EP Impurity L, Prednisolone 21-Acetate)
|
潑尼松龍EP雜質(zhì)C(醋酸氫化可的松EP雜質(zhì)C、醋酸甲基潑尼松酮EP雜質(zhì)E、潑尼松松EP雜質(zhì)L、潑尼松21醋酸酯)
|
52-21-1
|
Lurasidone Impurity 39
|
魯拉西酮雜質(zhì)39
|
1448443-35-3
|
Prednisolone Impurity 7
|
潑尼松龍雜質(zhì)7
|
61549-70-0
|
Lansoprazole Impurity 21
|
蘭索拉唑雜質(zhì)21
|
22710-07-2
|
Febuxostat Impurity 61
|
非布司他雜質(zhì)61
|
609-15-4
|
Vonoprazan Impurity 10
|
沃諾拉贊雜質(zhì)10
|
|
Desfluoro Nebivolol (Mixture of Diastereomers)
|
去氟奈比洛爾(雙立體異構(gòu)體混合物)
|
99200-13-2
|
Budesonide Impurity 9
|
布地奈德雜質(zhì)9
|
1188271-73-9
|
Landiolol Impurity 23
|
蘭地洛爾雜質(zhì)23
|
17362-17-3
|
Nintedanib Impurity 13 (Intedanib Impurity 13)
|
尼達尼布 雜質(zhì)13(阿達尼雜質(zhì)13)
|
|
Hydrocortisone EP Impurity K
|
氫化可的松EP雜質(zhì)K
|
640-87-9
|
Nintedanib Impurity 19
|
尼達尼布雜質(zhì)19對照品
|
|
Nintedanib Impurity 49
|
尼達尼布雜質(zhì)49對照品
|
380427-39-4
|
Landiolol Impurity 1
|
蘭地洛爾雜質(zhì)1
|
|
Regorafenib Impurity 21
|
瑞戈非尼雜質(zhì)21
|
|
Duloxetine EP Impurity F/Duloxetine Impurity 4
|
度洛西汀雜質(zhì)4(有出圖記錄)/度洛西汀EP雜質(zhì)F
|
116817-27-7
|
Formoterol Impurity 21
|
福莫特羅雜質(zhì)21對照品
|
43229-70-5
|
Vonoprazan Impurity 12
|
沃諾拉贊雜質(zhì)12
|
2169267-53-0
|
Formoterol EP Impurity D Formate (Mixture of Diastereomers)
|
福莫特羅 EP 雜質(zhì) D 甲酸鹽(非對映體混合物)對照品
|
1795133-96-8
|
Pantoprazole Impurity 9
|
泮托拉唑雜質(zhì)9
|
97963-75-2
|
Budesonide EP Impurity G (Budesonide USP Related Compound G, 1,2-Dihydro Budesonide) (Mixture of Diastereomers)
|
布地奈德EP雜質(zhì)G(布地奈德USP相關(guān)化合物G,1,2-二氫布地奈德)(雙立體異構(gòu)體混合物)
|
137174-25-5
|
Lenalidomide Impurity 11
|
來那度胺雜質(zhì)11
|
48103-74-8
|
Ilaprazole Impurity 2
|
艾普拉唑雜質(zhì)2
|
|
Vonoprazan Impurity 7
|
沃諾拉贊雜質(zhì)7
|
2416241-97-7
|
Formoterol EP Impurity A (Formoterol USP Related Compound A)
|
福莫特羅EP雜質(zhì)A對照品
|
150513-24-9
|
Vonoprazan Impurity 3 DiHCl
|
沃諾拉贊雜質(zhì)3二鹽酸鹽
|
928325-41-1
|
Paliperidone Meristoate
|
帕利哌酮分生組織
|
1172995-11-7
|
Lenalidomide Impurity 26
|
來那度胺雜質(zhì)26
|
1975-50-4
|
Lansoprazole Impurity 19
|
蘭索拉唑雜質(zhì)19
|
163119-28-6
|
Aripiprazole Impurity 15
|
阿立哌唑雜質(zhì)15
|
|
Paliperidone Impurity 12
|
帕利哌酮雜質(zhì)12
|
1117803-76-5
|
Famotidine Impurity 12
|
法莫替丁雜質(zhì)12
|
88061-72-7
|
Budesonide Impurity 1 (Mixture of Diastereomers)
|
布地奈德雜質(zhì)1(雙立體異構(gòu)體混合物)
|
|
Pantoprazole Impurity 37
|
泮托拉唑雜質(zhì)37
|
4780-14-7
|
Salmeterol EP Impurity C
|
沙美特羅EP雜質(zhì)C對照品
|
94749-11-8
|
4'-O-Demethyl Pantoprazole Sulfide
|
4'-O-脫甲基泮托拉唑硫化物
|
141854-21-9
|
Vonoprazan Impurity 38
|
沃諾拉贊雜質(zhì) 38
|
|
Nebivolol Impurity 2 HCl (SR,RS)
|
奈比洛爾雜質(zhì)2 HCl(SR,RS)
|
920275-19-0
|
Lurasidone Impurity 31
|
魯拉西酮雜質(zhì)31
|
|
Febuxostat Impurity 32 HCl
|
鹽酸非布司他雜質(zhì)32
|
1267681-15-1
|
Parecoxib Impurity 36 Sodium Salt
|
帕瑞昔布雜質(zhì)36鈉鹽
|
2229657-81-0
|
Prednisolone Impurity B Tetrasodium Diphosphate
|
潑尼松龍雜質(zhì)B二磷酸四鈉
|
|
Nintedanib Impurity 27
|
尼達尼布雜質(zhì)27對照品
|
|
Rasagiline Impurity 1 HCl
|
雷沙吉蘭雜質(zhì)1 HCl
|
1175018-75-3
|
Budesonide Impurity 4
|
布地奈德雜質(zhì)4
|
|
Regorafenib Impurity 19
|
瑞戈非尼雜質(zhì)19
|
|
Parecoxib Impurity 53
|
帕瑞昔布雜質(zhì)53
|
451-40-1
|
Paroxetine Related Impurity 6
|
帕羅西汀相關(guān)雜質(zhì)6
|
|
Methylprednisolone Impurity 1
|
甲潑尼松雜質(zhì)1
|
|
Methylprednisolone 21-Hemisuccinate (Methylprednisolone Hydrogen Succinate)
|
甲基潑尼松21半琥珀酸(甲基潑尼松龍琥珀酸氫鹽)
|
2921-57-5
|
Lenalidomide Impurity 22
|
來那度胺雜質(zhì)22
|
1240215-87-5
|
Lenalidomide Impurity 36
|
來那度胺雜質(zhì)36
|
764-28-3
|
Lansoprazole Impurity 28
|
蘭索拉唑雜質(zhì)28
|
|
Lansoprazole Impurity 20
|
蘭索拉唑雜質(zhì)20
|
168167-49-5
|
Metoclopramide EP Impurity C
|
甲氧氯普胺EP雜質(zhì)C
|
7206-70-4
|
alpha-Hydroxy Metoprolol
|
α-羥基美托洛爾
|
56392-16-6
|
Prednisolone Impurity 12
|
潑尼松龍雜質(zhì)12
|
|
Esmolol Dimer
|
艾司洛爾二聚體
|
98903-89-0
|
Hydrocortisone Impurity 53
|
氫化可的松雜質(zhì)53
|
|
Hydrocortisone Dimer Impurity 1
|
氫化可的松二聚體雜質(zhì)1
|
|
Hydrocortisone Impurity 20
|
氫化可的松雜質(zhì)20
|
103242-89-3
|
Paroxetine Impurity 21
|
帕羅西汀雜質(zhì)21
|
|
Fluticasone Impurity 19
|
氟替卡松雜質(zhì)19
|
|
Brexpiprazole Impurity 21
Brexpiprazole N,N-Dioxide
|
布瑞哌唑雜質(zhì)21
|
2247155-42-4
|
Febuxostat Impurity 53
|
非布司他雜質(zhì)53
|
|
Rasagiline Impurity 4 HCl
|
雷沙吉蘭雜質(zhì)4 HCl對照品
|
1175018-78-6
|
23-Chloro Budesonide
|
23氯布地奈德
|
|
Paliperidone Laurate
|
月桂酸帕利哌酮
|
|
Nintedanib Impurity 59
|
尼達尼布雜質(zhì)59對照品
|
|
Fluticasone Impurity 4
|
氟替卡松雜質(zhì)4
|
948565-92-2
|
Triamcinolone Acetonide Impurity 1
|
曲安奈德雜質(zhì)1
|
2367-73-9
|
11-epi-Prednisolone-21-Disodium Phosphate
|
11-表觀-強的松龍-21-磷酸二鈉
|
|
Landiolol Impurity 3
|
蘭地洛爾雜質(zhì)3
|
|
Lurasidone Impurity 26
|
魯拉西酮雜質(zhì)26
|
|
Vonoprazan Impurity 45 DiHCl
|
沃諾拉贊雜質(zhì) 45二鹽酸鹽
|
881733-45-5
|
Methylprednisolone Impurity 20
|
甲潑尼松雜質(zhì)20
|
|
Pregabalin Impurity 23
|
普瑞巴林雜質(zhì)23對照品
|
|
Nebivolol Impurity 38
|
奈比洛爾雜質(zhì)38
|
1323246-44-1
|
Parecoxib Impurity 1
|
帕瑞昔布雜質(zhì)1
|
57736-10-4
|
Bisoprolol Impurity 1
|
比索洛爾雜質(zhì)1
|
1346601-19-1
|
6-alpha-Chloro-Triamcinolone Acetonide Acetate
|
6-α-氯-曲安奈德醋酸酯
|
1181-32-4
|
Hydrocortisone Impurity 12
|
氫化可的松雜質(zhì)12
|
|
Parecoxib Impurity 44
|
帕瑞昔布雜質(zhì)44
|
|
Nebivolol Impurity 31
|
奈比洛爾雜質(zhì)31
|
|